COVID-19 Updates
From the Journals
Remdesivir may keep unvaccinated out of the hospital: Study
From the Journals
New studies suggest Omicron infections are less severe than Delta ones
News from the FDA/CDC
FDA authorizes Pfizer antiviral pill for COVID-19
From the Journals
Bamlanivimab’s effects in COVID-19 depend on antibodies
Bamlanivimab was more effective in hospitalized COVID-19 patients without endogenous neutralizing antibodies.
From the Journals
BMJ slams ‘incompetent’ Facebook fact-checking of vaccine article
The article in question investigated data integrity concerns at Pfizer vaccine clinical trial sites.
Latest News
COVID cases spike as questions remain about Omicron’s threat
The Omicron variant has been detected in at least 39 states and 75 countries, according to CDC director Rochelle Walensky, MD.
From the Journals
Small myocarditis risk now seen for adenovirus-based COVID-19 vaccine
The large-scale analysis suggests the risk is low with the adenovirus vaccine and pales in comparison with that following a positive SARS-CoV-2...
News from the FDA/CDC
CDC panel backs mRNA COVID vaccines over J&J because of clot risk
The risk of dying from TTS after a Johnson & Johnson shot is extremely rare.
From the Journals
COVID-19 asymptomatic infection rate remains high
“It is important to know the asymptomatic carrier rate among the general population for the future control of [the] pandemic,” said Dr. Setu...
Feature
12 state boards have disciplined docs for COVID misinformation
“The staggering number of state medical boards that have seen an increase in COVID-19 disinformation complaints is a sign of how widespread the...
Latest News
Major COVID-19 case growth expected in coming weeks
“Why? Simply stated, the large amount of Thanksgiving travel and gatherings undermined the nation’s pandemic footing.”